February 7, 2024

Unlocking the Potential of Enhertu: A Revolutionary Advance in Targeted Cancer Therapy

The development of Enhertu represents a significant advancement in targeted cancer therapy, offering new hope for patients with limited treatment options. Enhertu, also known as trastuzumab deruxtecan, is an innovative antibody-drug conjugate (ADC) designed to target HER2-positive cancers, which are associated with aggressive growth and poor prognosis in various cancer types, including breast and gastric cancers
January 22, 2024

Pluvicto: Most Asked Questions

"for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy."
January 19, 2024

Why Atezolizumab and Chemotherapy Should Be Used with Caution in Real-World SCLC Population

Atezolizumab, a programmed death-ligand 1 (PD-L1) inhibitor, has shown promising results in clinical trials when combined with chemotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC). However, a real-world evaluation of atezolizumab plus platinum-etoposide chemotherapy in patients with ES-SCLC in Canada raises important considerations regarding its use.
December 16, 2023

Navigating Complex Moral Choices in Obstetrics: The Intersection of Maternal Cancer and Pregnancy

During her rotation in obstetrics and gynecology, a resident encountered a 28-year-old pregnant woman at 13 weeks gestational age, who already has three healthy children. I […]
January 15, 2021

3 Highlights about Ovarian Cancer: Options and Risks

This is an important thing that's our patients are worried about this. And this is something that we, as a group need to ask ourselves, how can we improve our adherence? and how to deal with ovarian cancer: options and risks
January 15, 2021

4 Dimensions to Improve Cancer Patient Quality Of Life

Cancer care is advancing. And we have more and more clinical trials, as well as new agents that we need to always remain focused on what our treatments mean, in terms of quality of life for patients and for their families. Because for all of us, quality of life, remains the ultimate goal of all of our cancer treatments. # Cancer Patient Quality Of Life
4 Dimensions to Improve Cancer Patient Quality Of Life
This website uses cookies to improve your experience. By using this website you agree to our Cookie Policy.
Read more